Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic
Jessica Duncan Cance, Erin Doyle
Abstract
This study examined outpatient buprenorphine dispensing patterns in Texas before vs after the Drug Enforcement Administration temporarily relaxed outpatient buprenorphine prescribing regulations in March 2020 in response to the COVID-19 pandemic.
Topics & Concepts
MedicineBuprenorphinePandemicCoronavirus disease 2019 (COVID-19)Outpatient visits2019-20 coronavirus outbreakEmergency medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medical emergencyVirologyInternal medicineOpioidHealth careInfectious disease (medical specialty)Economic growthOutbreakEconomicsReceptorDiseaseOpioid Use Disorder TreatmentCOVID-19 and Mental HealthSuicide and Self-Harm Studies